NCT05620732View on ClinicalTrials.gov

Treatment of Advanced Malignant Solid Tumors With Claudin18.2CAR-T

NARecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

October 1, 2022

Primary Completion Date

October 31, 2025

Study Completion Date

October 31, 2028

Conditions
Advanced Pancreatic CarcinomaAdvanced Gastric Carcinoma
Interventions
BIOLOGICAL

Claudin18.2 CAR-T cells

patients treated with Claudin18.2 CAR-T cells

Trial Locations (1)

518000

RECRUITING

Li Yu, Shenzhen

All Listed Sponsors
lead

Shenzhen University General Hospital

OTHER